Publication for HMGCS1 and SCD
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 3157 | [link] | ||
| hsa | SCD | stearoyl-CoA desaturase | 6319 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 24493696 | 0.98 | SCD-1 for lipogenesis, HMGCS1, HMGCR, MVK, MVD and LDLR for cholesterogenesis, two chaperones, INSIG1 and SCAP. |
| 0.97 | SCD-1, HMGCS1, HMGCR, MVK, MVD and LDLR and two chaperones, INSIG-1 and SCAP in LNCaP and C4-2B cells examined by qRT-PCR. | |
| 0.97 | SCD-1, HMGCS1, HMGCR, MVK and MVD and two chaperones, INSIG-1 and SCAP compared to the control group. | |
| 0.97 | SCD-1, HMGCS1, HMGCR, MVK, MVD and LDLR, and further reduces the levels of intracellular fatty acid and cholesterol. | |
| 0.95 | SCD-1, HMGCS1, HMGCR, MVK, MVD, INSIG1 and SCAP (Fig. 5A). | |
| 26153245 | 0.98 | SCD, FADS1, HMGCS1, FDFT1, SQLE, CYP51A1, SC4MOL), and efflux ( ABCA1, ABCG1), producing a molecular profile expected to increase intracellular cholesterol. |
| 0.98 | SCD, FADS1, HMGCS1, FDFT1, SQLE, CYP51A1, SC4MOL), and cholesterol efflux ( ABCA1, ABCG1). | |
| 0.98 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1); farnesyl-diphosphate farnesyltransferase 1 (FDFT1); squalene epoxidase (SQLE); methylsterol monooxygenase 1 (SC4MOL); cytochrome P450, family 51, subfamily A, polypeptide 1 (CYP51A1); stearoyl-CoA desaturase (SCD); fatty acid desaturase 1 (FADS1); low density lipoprotein receptor (LDLR); myosin regulatory light chain interacting protein (MYLIP); ATP-binding cassette, subfamily G, member 1 (ABCG1); and ATP-binding cassette, subfamily A, member 1 (ABCA1). | |
| 0.95 | HMGCS1, FDFT1, SQLE, CYP51A1, SC4MOL, SCD, and FADS1), and 3 that were downregulated with increasing BMI (MYLIP, ABCG1, and ABCA1). | |
| 27811063 | 0.98 | HMGCS1, LSS, and SCD encode key enzymes in the pathways for cholesterol and unsaturated fatty acid biosynthesis (Fig. 3A), and the results presented in Fig. 2 suggest that the reaction products of these pathways might be essential for CSLC enrichment and survival. |
| 0.98 | HMGCS1, LSS, and SCD; Fig. 4). | |
| 0.71 | SCD, LSS, HMGCS1) critical for cholesterol and unsaturated fatty acid synthesis. | |
| 31932581 | 0.98 | SCD1, HMGCS1 and HMGCR in A2780 and SKOV3 cells with treatment as indicated. |
| 0.97 | SCD1) and cholesterol synthesis (HMGCS1, HMGCR). | |
| 0.86 | SCD1 and HMGCS1 were observed when SIK2 was knockdown or overexpressed in A2780 and SKOV3 cells. | |
| 28933554 | 0.98 | 3-Hydroxy-3-Methylglutaryl-CoA Synthase 1 (HMGCS1), 7-Dehydrocholesterol Reductase (DHCR7), Lanosterol Synthase (LSS), Stearoyl-CoA Desaturase (SCD), and Mevalonate Diphosphate Decarboxylase (MVD). |
| 29869753 | 0.98 | SCD, SCAP, SREBF1, SREBF2, MBTPS1, MBTPS2, LDLR, HMGCS1, LIMA1] in patient samples collected from metastatic vs. primary prostate cancer (a) and multiple myeloma vs. normal bone marrow (b). |
| 31159817 | 0.98 | HMGCS1, FDPS, LSS and SQLE) and lipogenic (e.g. ACACA, SCD, FASN, FADS1 and ELOVL6) pathways. |
| 31592021 | 0.98 | SCD increase expression by RT-qPCR in a time-dependent manner under sterol-depleted conditions supplemented with statin treatment (5% lipoprotein-deficient media with 5 microM simvastatin and 50 microM mavelonic acid) when compared to sterol-rich conditions (10% FBS) supplemented with DMSO vehicle control, similarly to SREBP2 and its downstream gene HMGCS1. |
| 23919967 | 0.97 | HMGCS*, CPT1A*, SCD1*, FASN*, CYP24A1*, SREBP1), thus reinforcing that a K-2/SXR mechanism is in effect. |
| 0.91 | HMGCS*, CPT1A*, SCD1*, FASN*, CYP24A1*, and SREBP1). | |
| 26133667 | 0.97 | SCD and HMGCS1 are regulators of inflammation and in lipid-related metabolism and pathology. |
| 0.95 | steroyl CoA desaturase-1 (SCD), and hydroxymethylglutaryl CoA synthase-1 (HMGCS1). | |
| 19560108 | 0.97 | SCD, HMGCS and HMGCR was activated 1.5 to 2.7-fold (p<0.001) by culture of freshly isolated trophoblast cells in the presence of 400 nMol/L oleate but not with 10 mMol/L glucose (Figure 4). |
| 31138790 | 0.97 | SCD1 and the HMGCS1, HMGCR and DHCR24 between ccRCC and adjacent tissues in the TCGA database. |
| 31316083 | 0.96 | SCD and ACLY mRNA expression is markedly elevated in SKCM versus healthy skin tissues (Supplementary Fig. 4b,c), while HMGCS1 is higher in the healthy tissues (Supplementary Fig. 4d). |
| 0.89 | SCD, ACLY and HMGCS1 expression using normalized RNA-Seq data from the SKCM group in TCGA and the normal skin tissue group in GTEx. | |
| 29153836 | 0.96 | SCD1, ACLY, ACSS2, HMGCS1, and MVD was markedly decreased by SRPK2 knockdown as well as by rapamycin treatment (Figure 5D). |
| 29404478 | 0.96 | SCD, HMGCR, or HMGCS1 mRNA was normalized by the level of ATP5F1 mRNA and assigned a value of 1 in the nontreated OR6Ac cells. |
| 24203995 | 0.93 | HMGCS, 3-hydroxy-3-methylglutaryl-CoA synthase; PPAP, phosphatidic acid phosphatase; SCD, stearoyl-CoA desaturase; SPHK, sphingosine-1-kinase. |
| 25811180 | 0.92 | HMGCS), fatty acid biosynthetic genes (FASN, SCD1) and genes involved in lipoprotein assembly (MTTP, APOC3) (Fig. 2B). |
| 21561152 | 0.90 | HMGCS; isopentenyl-diphosphate delta isomerase 1, IDI1; stearoyl-CoA desaturase, SCD1; LDL receptor, LDLR; ribosomal protein L13a, RPL13A; beta- 2 microglobulin, B2M; glyceraldehyde-3-phosphate dehydrogenase, GAPDH. |
| 25358453 | 0.86 | steroyl CoA desaturase-1, SCD, and hydroxymethylglutaryl CoA synthase 1, HMGCS1. |
| 0.83 | SCD and HMGCS1 are implicated in regulation of inflammation and in lipid-related metabolism and pathology. | |
| 29474981 | 0.73 | stearoyl CoA desaturase-1 (Scd1), LDL receptor (Ldlr), and HMG-CoA synthase (Hmgcs1), through a negative feedback loop. |
| 28352810 | 0.72 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and squalene epoxidase (SE) that are related with TC synthesis, acetyl-CoA carboxylase alpha (ACC), fatty acid synthase (FAS) and stearoyl-CoA desaturase that are related with FA synthesis. |
| 32180899 | 0.71 | HMGCS1, HMGCR, SCD1, FABP4, and SCD1are critical enzymes in the pathways of lipid synthesis as well cholesterol and steroid synthesis. |
| 17052361 | 0.55 | stearoyl-CoA desaturase (delta-9-desaturase; SCD1) (7.4, p = 0.000008), 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) (5.6, p = 0.000009), fatty acid synthase (FASN) (5.4, p = 0.000008), 7-dehydrocholesterol reductase (DHCR7) (4.3, p = 0.000008), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) (3.1, p = 0.00001), sterol-C5-desaturase like (SC5DL) (3.1, p = 0.00001), acetyl-CoA acetyltransferase 2 (also termed acetoacetyl-CoA thiolase; ACAT2) (3.0, p = 0.00009), low density lipoprotein receptor (LDLR) (2.8, p = 0.00001) and farnesyl diphosphate synthase (FDPS) (2.8, p = 0.000009). |
| 0.53 | HMGCS1, FDPS, SC5DL, DHCR7, LDLR, FASN and SCD1) in four CNS-relevant human cell lines. | |
| 31467349 | 0.55 | HMGCS1, LSS, PLOD1, and SCD) were found in cell communication and lipid metabolic process categories (blue in Fig. 3). |
The preparation time of this page was 0.0 [sec].
